Sarpogrelate hydrochloride tablets 50mg “Kemipha” from Nippon Chemipha contain Sarpogrelate hydrochloride, a selective 5-HT2A receptor antagonist. This medicine is used to inhibit platelet aggregation and vasoconstriction, improving blood flow, and is typically prescribed for ischemic symptoms associated with chronic arterial occlusion. The standard is 50mg per tablet (YJ code: 3399006F1174).
Sarpogrelate hydrochloride tablets 50mg “Kemipha”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
